title: Sustained Response to Vemurafenib in a BRAFV600E-Mutated Anaplastic Thyroid Carcinoma Patient.
authors.affiliation: 1 Department of Medicine I, Comprehensive Cancer Center Vienna; Medical University of Vienna , Vienna, Austria .
authors.forename: Gerald W
authors.initials: GW
authors.lastname: Prager
authors.affiliation: 2 Institute of Clinical Pathology; Medical University of Vienna , Vienna, Austria .
authors.forename: Oskar
authors.initials: O
authors.lastname: Koperek
authors.affiliation: 3 Departments of Biomedical Imaging and Image-Guided Therapy; Medical University of Vienna , Vienna, Austria .
authors.forename: Marius E
authors.initials: ME
authors.lastname: Mayerhoefer
authors.affiliation: 3 Departments of Biomedical Imaging and Image-Guided Therapy; Medical University of Vienna , Vienna, Austria .
authors.forename: Leonhard
authors.initials: L
authors.lastname: Muellauer
authors.affiliation: 3 Departments of Biomedical Imaging and Image-Guided Therapy; Medical University of Vienna , Vienna, Austria .
authors.forename: Fritz
authors.initials: F
authors.lastname: Wrba
authors.affiliation: 4 Department of Endocrine Surgery; Medical University of Vienna , Vienna, Austria .
authors.forename: Bruno
authors.initials: B
authors.lastname: Niederle
authors.affiliation: 1 Department of Medicine I, Comprehensive Cancer Center Vienna; Medical University of Vienna , Vienna, Austria .
authors.forename: Christoph C
authors.initials: CC
authors.lastname: Zielinski
authors.affiliation: 1 Department of Medicine I, Comprehensive Cancer Center Vienna; Medical University of Vienna , Vienna, Austria .
authors.forename: Markus
authors.initials: M
authors.lastname: Raderer
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D049268:Positron-Emission Tomography; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D013449:Sulfonamides / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics*; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf